Evaluation of the in vitro growth-inhibitory effect of epoxomicin on Babesia parasites

Veterinary Parasitology

Volumn 167, Issue 1, 2010, Pages 19-27

  AbouLaila, Mahmoud ^a   Nakamura, Kazuya ^a   Govind, Yadav ^a   Yokoyama, Naoaki ^a   Igarashi, Ikuo ^a  

^a OBIHIRO UNIVERSITY OF AGRICULTURE AND VETERINARY MEDICINE   (Japan)

Author keywords

Babesia; Epoxomicin; In vitro

Indexed keywords

DIMINAZENE ACETURATE; EPOXOMICIN; PLACEBO; PROTEASOME; TETRACYCLINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BABESIA; BABESIA BIGEMINA; BABESIA BOVIS; BABESIA CABALLI; BABESIA EQUI; BABESIA MICROTI; BABESIA OVATA; BABESIOSIS; CELL DEATH; CELL PROLIFERATION; CONTROLLED STUDY; DRUG DOSE COMPARISON; DRUG POTENTIATION; ENZYME INHIBITION; ENZYME MECHANISM; FEMALE; GROWTH INHIBITION; IC 50; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; UBIQUITINATION;

ANIMALS; BABESIA; BABESIOSIS; BIOLOGICAL ASSAY; CATTLE; CATTLE DISEASES; CELL SURVIVAL; CERCOPITHECUS AETHIOPS; ENZYME INHIBITORS; ERYTHROCYTES; FEMALE; HORSE DISEASES; HORSES; INHIBITORY CONCENTRATION 50; MICE; MICE, INBRED BALB C; OLIGOPEPTIDES; VERO CELLS;

BABESIA; BABESIA BIGEMINA; BABESIA BOVIS; BABESIA CABALLI; BABESIA EQUI; BABESIA MICROTI; BABESIA OVATA; BOVINAE; EQUIDAE; MUS;

EID: 71849102024     PISSN: 03044017     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetpar.2009.09.049     Document Type: Article

References (37)

1. Bork S., Yokoyama N., Matsuo T., Claveria F.G., Fujisaki K., and Igarashi I. Growth inhibitory effect of triclosan on equine and bovine Babesia parasites. Am. J. Trop. Med. Hyg. 68 (2003) 334-340
2. Bork S., Yokoyama N., Matsuo T., Claveria F.G., Fujisaki K., and Igarashi I. Clotrimazole, ketoconazole, and clodinafop-propargyl as potent growth inhibitors of equine Babesia parasites during in vitro culture. J. Parasitol. 89 (2003) 604-606
3. Bork S., Yokoyama N., Matsuo T., Claveria F.G., Fujisaki K., and Igarashi I. Clotrimazole, ketoconazole, and clodinafop-propargyl inhibit the in vitro growth of Babesia bigemina and Babesia bovis (Phylum Apicomplexa). Parasitology 127 (2003) 311-315
4. Bork S., Yokoyama N., Ikehara Y., Kumar S., Sugimoto C., and Igarashi I. Growth-inhibitory effect of heparin on Babesia parasites. Antimicrob. Agents Chemother. 48 (2004) 236-241
5. Bork S., Okamura M., Matsuo T., Kumar S., Yokoyama N., and Igarashi I. Host serum modifies the drug susceptibility of Babesia bovis in vitro. Parasitology 130 (2005) 489-492
6. Bork S., Yokoyama N., and Igarashi I. Recent advances in the chemotherapy of babesiosis by Asian scientists. Toxoplasmosis and Babesiosis in Asia. Asian Parasitol. 4 (2005) 233-242
7. Bork S., Das S., Okubo K., Yokoyama N., and Igarashi I. Effects of protein kinase inhibitors on the in vitro growth of Babesia bovis. Parasitology 132 (2006) 775-779
8. Brasseur P., Lecoublet S., Kapel N., Favennec L., and Ballet J. In vitro evaluation of drug susceptibilities of Babesia divergens isolates. Antimicrob. Agent Chemother. 42 (1998) 818-820
9. Chouby V., Maity P., Guha M., Kumar S., Srivastava K., Puri S., and Bandyopadhyay U. Inhibition of Plasmodium falciparum choline kinase by hexadecyltrimethylammonium bromide: a possible antimalarial mechanism. Antimicrob. Agents Chemother. 51 (2007) 696-706
10. Ciechanover A. The ubiquitin-proteasome pathway: on protein death and cell life. EMBO J. 17 (1998) 7151-7160
11. deVries E., Corton C., Harris B., Cornelissen A., and Berriman M. Expressed sequence tag (EST) analysis of the erythrocytic stages of Babesia bovis. Vet. Parasitol. 138 (2006) 61-74
12. Estacia P., Rodrigues A., Moreira P., and Genari S. The cytotoxicity in vero cells of a perflurocarbon used in vitro retinal surgery. Braz. J. Morphol. Sci. 19 (2002) 41-47
13. Garrett I., Chen D., Gutierrez G., Zhao M., Escobedo A., Rossini G., Harris S., Gallwitz W., Kim K., Hu S., Crews C., and Mundy G.R. Selective inhibitors of the osteoblast proteasome stimulate bone formation in vivo and in vitro. J. Clin. Invest. 111 (2003) 1771-1782
14. Hilt W., and Wolf D. Proteasomes: destruction as a programme. Trends Biochem. Sci. 21 (1996) 96-102
15. Homer M.J., Aguilar-Delfin I., Telford III S.R., Krause P.J., and Persing D.H. Babesiosis. Clin. Microbiol. Rev. 13 (2000) 451-469
16. Ica A., Vatansever Z., and Inci A. Bovine babesiosis in Turkey. Babesia World Summit. Bunis Aires, Argentina (2005) p. 12
17. Ica A., Vatansever Z., Yildirim A., Duzlu O., and Inci A. Investigation of ovine blood protozoa by reverse line blotting in the Kayseri region. Parasitologia 49 (2007) 90
18. Igarashi I., Avarzed A., Tanaka T., Inoue N., Ito M., Omata Y., Saito A., and Suzuki N. Continuous in vitro cultivation of Babesia ovata. J. Protozool. Res. 4 (1994) 111-293
19. Igarashi I., Njonge F., Kaneko Y., and Nakamura Y. Babesia bigemina: in vitro and in vivo effects of curdlan sulfate on the growth of parasites. Exp. Parasitol. 90 (1998) 290-293
20. Inci A. Detection of Babesia caballi (Nuttall, 1901) and Babesia equi (Laveran, 1901) in horses by microscopic examination in military farm in Gemlik. T. J. Vet. Anim. Sci. 21 (1997) 43-46
21. Kikuchi S., Shinpo K., Tsuji S., Takeuchi M., Yamagishi S., Makita Z., Niino M., Yabe I., and Tashiro K. Effects of proteasome inhibitor on cultured mesencephalic dopamenergic neurons. Brain Res. 964 (2003) 228-236
22. Kim K.B., Myung J., Sin N., and Crews C.M. Proteasome inhibition by the natural products epoxomicin and dihydroeponemycin: insights into specificity and potency. Bioorg. Med. Chem. Lett. 9 (1999) 3335-3340
23. Kjemtrup A.M., and Conrad P.A. Human babesiosis: an emerging tick-borne disease. Int. J. Parasitol. 30 (2000) 1323-1337
24. Kreidenweiss A., Kremsner P.G., and Mordmüller B. Comprehensive study of proteasome inhibitors against Plasmodium falciparum laboratory strains and field isolates from Gabon. Malaria J. 7 (2008) 187-195
25. Kuttler K.L. World-wide impact of babesiosis. In: Risitic M. (Ed). Babesiosis of Domestic Animals and Man (1988), CRC Press, Inc., Boca Raton, FL 2-22
26. Matsuu A., Yamasaki M., Xuan X., Ikadai H., and Hikasa Y. In vitro evaluation of the growth inhibitory activities of 15 drugs against Babesia gibsoni (Aomori strain). Vet. Parasitol. 157 (2008) 1-8
27. Mehlhorn H., and Schein E. Redescription of Babesia equi Laveran, 1901 as Theileria equi. Parasitol. Res. 84 (1998) 467-475
28. Meng L., Mohan R., Kowk B., Elofsson M., Sin N., and Crews C.M. Epoxomicin, a potent and selective proteasome inhibitor, exhibits in vivo anti-inflammatory activity. Proc. Natl. Acad. Sci. U.S.A. 96 (1999) 10403-10408
29. Mordmüller B., Fendel R., Kreidenweiss A., Gille C., Hurwitz R., Metzger W., Kun J., Lamkemeyer T., Nordheim A., and Kremsner P.G. Plasmodia express two threonine-peptidase complexes during asexual development. Mol. Biochem. Parasitol. 148 (2006) 79-85
30. Nagai A., Yokoyama N., Matsuo T., Bork S., Hirata H., Xuan X., Zhu Y., Claveria F.G., Fujisaki K., and Igarashi I. Growth-inhibitory effects of artesunate, pyrimethamine, and pamaquine against Babesia equi and Babesia caballi in in vitro cultures. Antimicrob. Agents Chemother. 47 (2003) 800-803
31. Nakamura K., Yokoyama N., and Igarashi I. Cyclin-dependent kinase inhibitors block erythrocyte invasion and intraerythrocytic development of Babesia bovis in vitro. Parasitology 135 (2007) 1-7
32. Nishisaka M., Yokoyama N., Xuan X., Inoue N., Nagasawa H., Fujisaki K., Mikami T., and Igarashi I. Characterization of the gene encoding a protective antigen from Babesia microti identified it as the ή subunit of chaperonin-containing T-complex protein 1. Int. J. Parasitol. 31 (2001) 1673-1679
33. Nott S.E., O'Sullivan W.J., Gero A.M., and Bagnara A.S. Routine screening for potential babesiacides using cultures of Babesia bovis. Int. J. Parasitol. 20 (1990) 797-802
34. Okubo K., Yokoyama N., Govind Y., Alhassan A., and Igarashi I. Babesia bovis: effects of cysteine protease inhibitors on in vitro growth. Exp. Parasitol. 117 (2007) 214-217
35. Varshavsky A. The ubiquitin system. Trends Biochem. Sci. 22 (1997) 383-387
36. Vial H.J., and Gorenflot A. Chemotherapy against babesiosis. Vet. Parasitol. 138 (2006) 147-160
37. Yokoyama N., Bork S., Nishisaka M., Hirata H., Matsuo T., Inoue N., Xuan X., Suzuki H., Sugimoto C., and Igarashi I. Roles of the Maltese cross form in the development of parasitemia and protection against Babesia microti infection in mice. Infect. Immun. 71 (2003) 411-417